000 01742 a2200505 4500
005 20250516115818.0
264 0 _c20130114
008 201301s 0 0 eng d
022 _a1939-327X
024 7 _a10.2337/db11-1655
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSivaskandarajah, Gavasker A
245 0 0 _aVegfa protects the glomerular microvasculature in diabetes.
_h[electronic resource]
260 _bDiabetes
_cNov 2012
300 _a2958-66 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aApoptosis
650 0 4 _aCells, Cultured
650 0 4 _aDiabetes Mellitus, Type 1
_xblood
650 0 4 _aDiabetic Nephropathies
_xmetabolism
650 0 4 _aDisease Progression
650 0 4 _aEndothelium, Vascular
_xmetabolism
650 0 4 _aHumans
650 0 4 _aHyperglycemia
_xetiology
650 0 4 _aKidney Glomerulus
_xblood supply
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aMice, Transgenic
650 0 4 _aMicrovessels
_xmetabolism
650 0 4 _aPodocytes
_xmetabolism
650 0 4 _aProteinuria
_xetiology
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aRandom Allocation
650 0 4 _aRecombinant Proteins
_xantagonists & inhibitors
650 0 4 _aUp-Regulation
_xdrug effects
650 0 4 _aVascular Endothelial Growth Factor A
_xantagonists & inhibitors
700 1 _aJeansson, Marie
700 1 _aMaezawa, Yoshiro
700 1 _aEremina, Vera
700 1 _aBaelde, Hans J
700 1 _aQuaggin, Susan E
773 0 _tDiabetes
_gvol. 61
_gno. 11
_gp. 2958-66
856 4 0 _uhttps://doi.org/10.2337/db11-1655
_zAvailable from publisher's website
999 _c22208564
_d22208564